Investor Briefing with James McDonnell – 4 Feb 2026
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Shareholder Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Q&A Update with Dr James Campbell Reach Markets recently interviewed Dr James Campbell...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO and Managing Director, James McDonnell, held...
Prescient Therapeutics: Q&A Update with Professor H. Miles Prince Reach Markets recently interviewed Professor H....
Prescient Therapeutics: Mariam Mansour, PhD Mariam Mansour, PhD, Director of Clinical Development and Translational Sciences...

This investor centre was built by Reach Markets
©2026 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.